Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer.

Swiss medical weekly - 21 Apr 2001

Schoumacher F, Glaus A, Mueller H, Eppenberger U, Bolliger B, Senn H J

Abstract excerpt

QUESTIONS UNDER STUDY: Germ-line alterations in BRCA1 and BRCA2 genes account for 30-50% of all forms of familial breast and ovarian cancer syndromes. Specific mutations in specific populations and ethnic groups have been identified in BRCA1 and BRCA2. However, it is not known whether such specific mutations prevail in the Swiss population. METHODS: We started to screen patients with primary breast and ovarian...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Genes, BRCA1
Share to Genes, Tumor Suppressor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoplasm Proteins

Share to Neoplastic Syndromes, Hereditary

Share to Ovarian Neoplasms

Share to Risk Assessment

Share to Switzerland

Source

Identifiers

PMID: 11400546
DOI: 10.4414/smw.2001.09677

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer.PMID 11400546Read ↗

BRCA1/2 germline missense mutations: a systematic review.Semantic proximity Read ↗

Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.Semantic proximity Read ↗

Breast cancer susceptibility genes. BRCA1 and BRCA2.Semantic proximity Read ↗

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families.Semantic proximity Read ↗

Identification of a novel pathogenic mutation in BRCA2 in a Spanish breast-ovarian cancer family.Semantic proximity Read ↗

Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.Semantic proximity Read ↗

Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.Semantic proximity Read ↗

Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.Semantic proximity Read ↗

Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer.Semantic proximity Read ↗

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.Semantic proximity Read ↗

Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in LebanonSemantic proximity Read ↗

Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.